Catalyst Wire Dossier Catalyst Wire Dossier

TH104

· Tharimmune Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TH104, covering 2025-04-08 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis [Phase 2]

See pricing